TotalMarketCap

Milestone Pharmaceuticals

MISTNasdaq CanadaHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$86.028 M

$0.69 -10.55%

Close of 6 Nov 2026

As of 6 Nov 2026, Milestone Pharmaceuticals (MIST) has a market capitalization of $86.0M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$63.1K

Loss-making

Shares outstanding

124,497,980

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #298Polaryx TherapeuticsPLYX$89.7M
  2. #299vTv TherapeuticsVTVT$86.4M
  3. #300Milestone PharmaceuticalsMIST$86.0M
  4. #301RallybioRLYB$84.7M
  5. #302Retension PharmaceuticalsRTSN$83.4M

What if Milestone Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $28.2T

$226,805.88

Per share 328,228× higher

Bitcoin $1.53T

$12,272.07

Per share 17,760× higher

Apple $5.02T

$40,288.06

Per share 58,304× higher

Or at a round number

$200.0M$500.0M$1.00B$2.00B

Where these numbers come from

Share counts and financials for Milestone Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.